“I consider that over the last three years the company has achieved significant outcomes, including a complete restructure and change management and business improvement programme and achieved to maintain strong service delivery outcomes, significant developments in terms of its focus on its core programmes, TBfree and NAIT, the development of new initiatives and the confirmation of its strategic plan despite the significant funding reduction.”
Chairman Jeff Grant said “Michelle has made a big contribution to the reshaping of OSPRI since joining the company.”
“This included a restructuring of the TBfree programme and dealing with $20 million reduction of funding for TBfree.
“This required downsizing the business to better fit the requirements of risk-based testing and the eventual eradication of TB in New Zealand. Michelle has played a major role in also ensuring the Nait review was completed, which will see changes implemented that give a more usable system for the industry and confidence in providing the intended outcomes when it was first set up.”
The board will start recruiting for a replacement and Edge would stay on to ensure that a seamless hand over will take place at the time of the new appointment, Grant said.
